<DOC>
	<DOC>NCT02770950</DOC>
	<brief_summary>The purpose of this study is to further evaluate the clinical efficacy and safety of Zushima plaster for patients in knee osteoarthrosis post-marketing.</brief_summary>
	<brief_title>Zushima Plaster for Treating Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Ages 4075; Unilateral or bilateral knee OA, confirmed radiographically; Patients taking oral NSAIDs prior to the breakthrough period will be permitted; VAS pain score is or above 20mm. Knee is swollen and hot; Allergic to any ingredient in Girald Daphne Bark Plaster (Girald Daphne Bark, Lithargite, Linseed oil, Red lead) ; Congestive Heart Failure and Edema; Advanced renal disease; Knee joint skin is burst or skin disease or allergies.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Knee Osteoarthritis</keyword>
</DOC>